Relationship between aggregation properties and antimicrobial activities of alkylphosphocholines with branched alkyl chains

International Journal of Pharmaceutics

Volumn 423, Issue 2, 2012, Pages 247-256

  Lukáč, Miloš ^a   Garajová, Mária ^a   Mrva, Martin ^a   Bukovský, Marián ^a   Ondriska, František ^b   Máriássy, Eszter ^a   Devínsky, Ferdinand ^a   Lacko, Ivan ^a  

^a Physics and Informatics   (Slovakia)

^b HPL spol s ro   (Slovakia)

Author keywords

Acanthamoeba spp.; Alkylphosphocholines; Critical micelle concentration; Miltefosine; Trophozoite

Indexed keywords

2 BUTYLOCTYL 2 (TRIMETHYLAMMONIO)ETHYL PHOSPHATE; 2 DECYLTETRADECYL 2 (TRIMETHYLAMMONIO)ETHYL; 2 ETHYLHEXYL 2 (TRIMETHYLAMMONIO)ETHYL PHOSPHATE; 2 HEXYLDECYL 2 (TRIMETHYLAMMONIO)ETHYL PHOSPHATE; 2 OCTYLDODECYL 2 (TRIMETHYLAMMONIO)ETHYL PHOSPHATE; ANTIINFECTIVE AGENT; MILTEFOSINE; UNCLASSIFIED DRUG;

ACANTHAMOEBA; ANTIMICROBIAL ACTIVITY; AQUEOUS SOLUTION; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; CRITICAL MICELLE CONCENTRATION; DRUG CYTOTOXICITY; DRUG DETERMINATION; ESCHERICHIA COLI; IN VITRO STUDY; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; SURFACE TENSION;

ACANTHAMOEBA; ANTI-INFECTIVE AGENTS; CANDIDA ALBICANS; ESCHERICHIA COLI; MICELLES; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; PHOSPHORYLCHOLINE; STAPHYLOCOCCUS AUREUS; STRUCTURE-ACTIVITY RELATIONSHIP; TIME FACTORS;

EID: 84856510538     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.11.047     Document Type: Article

References (70)

1. M.G. Aguiar, A.M.M. Pereira, A.P. Fernandes, and L.A.M. Ferreira Reductions in skin and systemic parasite burdens as a combined effect of topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leismania (Leishmania) amazonensis Antimicrob. Agents Chemother. 54 2010 4699 4704
2. A.C. Aichelburg, J. Walochnik, O. Assadian, H. Prosch, A. Steuer, G. Perneczky, G.S. Visvesvara, H. Aspöck, and N. Vetter Successful treatment of disseminated Acanthamoeba sp. infection with miltefosine Emerg. Infect. Dis. 14 2008 1743 1746
3. P. Babu, D. Chopra, T.N. Guru Row, and U. Maitra Micellar aggregates and hydrogels from phosphonobile salts Org. Biomol. Chem. 3 2005 3695 3700 (Pubitemid 41603766)
4. P. Balgavý, and F. Devínsky Cut-off effects in biological activities of surfactants Adv. Colloid Interface Sci. 66 1996 23 63 (Pubitemid 126399445)
5. C. Blaha, M. Duchêne, H. Aspöck, and J. Walochnik In vitro activity of hexadecylphosphocholine (miltefosine) against metronidazole- resistant and -susceptible strains of Trichomonas vaginalis J. Antimicrob. Chemother. 57 2006 273 278 (Pubitemid 43160169)
6. T. Calogeropoulou, P. Angelou, A. Detsi, I. Fragiadaki, and E. Scoulica Design and synthesis of potent antileishmanial cycloalkylidene-substituted ether phospholipid derivatives J. Med. Chem. 51 2008 897 908 (Pubitemid 351304697)
7. H.D. Frankel, and G. Chen Enteropathogenic Escherichia coli: unravelling pathogenesis FEMS Microbiol. Rev. 29 2005 83 98
8. A. Christiansen, T. Backensfeld, and W. Weitschies Effects of non-ionic surfactants on in vitro triglyceride digestion and their susceptibility to digestion by pancreatic enzymes Eur. J. Pharm. Sci. 41 2010 376 382
9. A. Colomer, A. Pinazo, M.A. Manresa, M.P. Vinardell, M. Mitjans, M.R. Infante, and L. Perez Cationic surfactants derived from lysine: effects of their structure and charge type on antimicrobial and hemolytic activities J. Med. Chem. 54 2011 989 1002
10. S.L. Croft, K. Seifert, and M. Duchêne Antiprotozoal activities of phospholipid analogues Mol. Biochem. Parasit. 126 2003 165 172 (Pubitemid 36255615)
11. P. Cugh, B. Bradel-Tretheway, C.M.R. Monteiro-Filho, V. Planalles, S.B. Maggirwar, S. Dewhurst, and B. Kim Akt inhibitors as an HIV-I infected macrophage-specific anti-viral therapy Retrovirology 5 2008 (art. no. 11)
12. M.A. Desando, and L.W. Reeves The effects of high temperatures (29-123 °C) on critical micelle concentrations in solutions of potassium n-octanoate in deuterium oxide: a nuclear magnetic resonance study Can. J. Chem. 64 1986 1823 1828
13. F. Devínsky, I. Lacko, D. Mlynarčík, V. Račanský, and Ľ. Krasnec Tenside Deterg. 22 1985 10 15
14. F. Devínsky, A. Kopecká-Leitmanová, F. Šeršeň, and P. Balgavý Cut-off effect in antibacterial activity and in membrane perturbation efficiency of the homologous series of NN-dimethylalkylamine ocides J. Pharm. Pharmacol. 42 1990 790 794
15. F. Devínsky, I. Lacko, and D. Mlynarčík Aggregation properties as a measure of lipophilicity in QSAR studies of antimicrobially active amphiphiles M. Kuchař, V. Rejholec, QSAR in Design of Bioactive Compounds 1992 Prous Int. Pub. Barcelona 233 247
16. C.S. Farah, R.B. Ashman, and S.J. Challacombe Oral candidosis Clin. Dermatol. 18 2000 553 562
17. P. Franois, A. Scherl, D. Hochstrasser, and J. Schrenzel Proteomic approaches to study Staphylococcus aureus pathogenesis J. Proteomics 73 2010 701 708
18. K. Griewank, C. Gazeau, A. Eichhorn, and E. Von Stebut Miltefosine efficiently eliminates Leishmania major amastigotes from infected murine dendritic cells without altering their immune functions Antimicrob. Agents Chemother. 54 2010 652 659
19. K. Hiramatsu, L. Cui, M. Kuroda, and T. Ito The emergence and evolution of methicillin-resistant Staphylococcus aureus Trends Microbiol. 9 2001 486 493 (Pubitemid 32939356)
20. R. Hirt, and R. Brechtold Zur Synthese der Phosphatide. 2. Eine neue Synthese der Lecithine Pharm. Acta Helv. 33 1958 349 356
21. V. Hornillos, E. Carrillo, L. Rivas, F. Amat-Guerri, and A.U. Acuña Synthesis of BODIPY-labeled alkylphosphocholines with leishmanicidal activity, as fluorescent analogues of miltefosine Bioorg. Med. Chem. Lett. 18 2008 6336 6339
22. W.H. Houlihan, M. Lohmeyer, P. Workman, and S.H. Cheon Phospholipid antitumor agents Med. Res. Rev. 15 1995 157 223
23. M.S. Kabir-ud-Din, S. Sheikh, and A.A. Dar Interaction of a cationic gemini surfactant with conventional surfactants in the mixed micelle and monolayer formation in aqueous medium J. Colloid Interface Sci. 333 2009 605 612
24. E.C. Kang, S. Kataoka, and K. Kato Synthesis and properties of alkyl phosphorylcholine amphiphiles with a linear and an asymmetrically branched alkyl chain Bull. Chem. Soc. Jpn. 78 2005 1558 1564 (Pubitemid 41176461)
25. N.A. Khan Acanthamoeba, Biology and Pathogenesis 2009 Caister Academic Press Norfolk, UK
26. S. Kilvington, W. Heaselgrave, M.J. Lally, K. Ambrus, and H. Powell Encystment of Acanthamoeba during incubation in multipurpose contact lens disinfectant solutions and experimental formulations Eye Contact Lens 34 2008 133 139
27. J. Klieščiková, J. Kulda, and E. Nohýnková Propylene glycol and contact-lens solutions containing this diol induce pseudocyst formation in acanthamoebae Exp. Parasitol. 127 2011 326 328
28. J. Klieščiková, J. Kulda, and E. Nohýnková Stress-induced pseudocyst formation - a newly identified mechanism of protection against organic solvents in acanthamoebae of the T4 genotype Protist 162 2011 58 59
29. M. Koufaki, V. Polychroniou, T. Calogeropoulou, A. Tsotinis, M. Drees, H.H. Fiebig, S. LeClerc, H.R. Hendriks, and A. Makriyannis Alkyl and alkoxyethyl antineoplastic phospholipids J. Med. Chem. 39 1996 2609 2614 (Pubitemid 26199151)
30. D. Llull, L. Rivas, and E. García In vitro bactericidal activity of the antiprotozoal drug miltefosine against Streptococcus pneumoniae and other pathogenic streptococci Antimicrob. Agents Chemother. 51 2007 1844 1848 (Pubitemid 46744170)
31. J. Lonnen, W. Heaselgrave, M. Nomachi, O. Mori, and J. Santodomingo-Rubido Disinfection efficacy and encystment rate of soft contact lens multipurpose solutions against Acanthamoeba Eye Contact Lens 36 2010 1 7
32. R. López-Martínez Candidosis, a new challenge Clin. Dermatol. 28 2010 178 184
33. Q. Lu, R.P. Ubillas, Y. Zhou, L.G. Dubenko, J.M. Dener, J. Litvak, P.W. Phuan, M. Flores, Z.J. Ye, R.E. Gerber, T. Truong, and D.E. Bierer Synthetic analogues of irlbacholine: a novel antifungal plant metabolite isolated from Irlbachia alata J. Nat. Prod. 62 1999 824 828 (Pubitemid 29296316)
34. M. Lukáč, J. Mojžiš, G. Mojžiš ová, M. Mrva, F. Ondriska, J. Valentová, I. Lacko, M. Bukovský, F. Devínsky, and J. Karlovská Dialkylamino and nitrogen heterocyclic analogues of hexadecylphosphocholine and cetyltrimetylammonium bromide: effect of phosphate group and environment of the ammonium cation on their biological activity Eur. J. Med. Chem. 44 2009 4970 4977
35. M. Lukáč, M. Mrva, E. Fischer-Fodor, I. Lacko, M. Bukovský, N. Miklášová, F. Ondriska, and F. Devínsky Synthesis and biological activity of dialkylphosphocholines Bioorg. Med. Chem. Lett. 19 2009 6346 6349
36. M. Lukáč, I. Lacko, M. Bukovský, Z. Kyselová, J. Karlovská, B. Horváth, and F. Devínsky Synthesis and antimicrobial activity of a series of optically active quaternary ammonium salts derived from phenylalanine Cent. Eur. J. Chem. 8 2010 194 201
37. M. Lukáč, M. Pisárčik, I. Lacko, and F. Devínsky Surface-active properties of nitrogen heterocyclic and dialkylamino derivates of hexadecylphosphocholine and cetyltrimethylammonium bromide J. Colloid Interface Sci. 347 2010 233 240
38. M. Lukáč, L. Timko, M. Mrva, F. Ondriska, J. Karlovská, J. Valentová, and I. Lacko Synthesis, aggregation properties, and antiprotozoal activity of heterocyclic heterogemini surfactants Heteroatom. Chem. 21 2010 203 209
39. M. Lukáč, I. Prokipčák, I. Lacko, and F. Devínsky Solubilisation of griseofulvin and rutin in aqueous micellar solutions of gemini and heterogemini surfactants and their mixtures Eur. J. Pharm. Sci. 44 2011 194 199
40. H.C. Maltezou, and H. Giamarellou Community-acquired methicillin- resistant Staphylococcus aureus infections Int. J. Antimicrob. Agents 27 2006 87 96 (Pubitemid 43138839)
41. J. McBride, P.R. Ingram, F.L. Henriquez, and C.W. Roberts Development of colorimetric microtiter plate assay for assessment of antimicrobials against Acanthamoeba J. Clin. Microbiol. 43 2005 629 634 (Pubitemid 40256011)
42. J. McBride, A.B. Mullen, C. Carter, and C.W. Roberts Differential cytotoxicity of phospholipid analogues to pathogenic Acanthamoeba species and mammalian cells J. Antimicrob. Chemother. 60 2007 521 525 (Pubitemid 47299865)
43. 13C NMR investigation of the structure of alkylammonium chloride micells in aqueous solutions J. Struct. Chem. 51 2010 1111 1118
44. M. Mrva, M. Garajová, M. Lukáč, and F. Ondriska Weak cytotoxic activity of miltefosine against clinical isolates of Acanthamoeba spp. J. Parasitol. 97 2011 538 540
45. V. Nagyova, A. Nagy, and J. Timko Morphological, physiological and molecular biological characterisation of isolates from first cases of Acanthamoeba keratitis in Slovakia Parasitol. Res. 106 2010 861 872
46. D. Obando, F. Widmer, L.C. Wright, T.C. Sorrell, and K.A. Jolliffe Synthesis, antifungal and antimicrobial activity of alkylphospholipids Bioorg. Med. Chem. 15 2007 5158 5165 (Pubitemid 46887671)
47. F. Ondriska, M. Mrva, M. Lichvár, P. Žiak, Z. Murgašová, A. Bieliková, K. Gablasová, and E. Nohýnková K. Furková, Akantamébová keratitída-novoobjavená humánna parazitóza na Slovensku 2006 Novinky v pediatrii III Bratislava 46 48
48. A.G. Ortega-Loayza, S.A. Diamantis, P. Gilligan, and D.S. Morrell Characterization of Staphylococcus aureus cutaneous infections in a pediatric dermatology tertiary health care outpatient facility J. Am. Acad. Dermatol. 62 2010 804 811
49. F.C. Page Nackte rhizopoda F.C. Page, F.J. Siemensma, Nackte Rhizopoda und Heliozoea. G 1991 Fischer Verlag Stuttgart, New York 1 170
50. I. Papanastasiou, K.C. Prousis, K. Georgikopoulou, T. Pavlidis, E. Scoulica, N. Kolocouris, and T. Calogeropoulou Design and synthesis of new adamantyl-substituted antileishmanial ether phospholipids Bioorg. Med. Chem. Lett. 20 2010 5484 5487
51. A. Peresypkin, C. Clavel, and F.M. Menger Ambidextrous 'hybrid' fluorinated zwitterionic geminis: self-assembly in both organic and aqueous media Mendeleev. Commun. 17 2007 82 84
52. P.M. Pinto, R. de Cássia Botelho Weikert-Oliveira, J. Pereira Lyon, V.F. Cury, R.R. Arantes, C.Y. Koga-Ito, and M.A. Resende In vitro antifungal susceptibility of clinical isolates of Candida spp. obtained from patients with different predisposing factors to candidosis Microbiol. Res. 163 2008 579 585
53. 31P nuclear magnetic resonance study on the incorporation of monomeric phospholipids into nonionic detergent micelles J. Phys. Chem. 85 1981 678 683
54. Polat, Z.A., Obwaller, A., Vural, A., Walochnik, J., 2011. Efficacy of miltefosine for topical treatment of Acanthamoeba keratitis in Syrian hmasters. Parasitol. Res., doi:10.1007/s00436-011-2515-0, in press.
55. M.J. Rosen Surfactants and Interfacial Phenomena 3rd ed. 2004 John Wiley & Sons Inc. New Jersey
56. +-ATPase and protein kinase C are targets to 1-O-hexadecylphosphocoline (miltefosine) in Trypanosoma cruzi Arch. Biochem. Biophys. 481 2009 65 71
57. F.L. Schuster, and G.S. Visvesvara Free-living amoeba as opportunistic and non-opportunistic pathogens of human and animals Int. J. Parasitol. 34 2004 1001 1027 (Pubitemid 39106843)
58. F.L. Schuster, and G.S. Visvesvara Opportunistic amoebae: challenges in prophylaxis and treatment Drug Resist. Updat. 7 2004 41 51 (Pubitemid 38453835)
59. F.L. Schuster, B.J. Guglielmo, and G.S. Visvesvara In-vitro activity of miltefosine and Voriconazole on clinical isolates of free-living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri J. Eukaryot. Microbiol. 53 2006 121 126 (Pubitemid 43357017)
60. K. Seifert, M. Duchêne, W.H. Wernsdorfer, H. Kollaritsch, O. Scheiner, G. Wiedermann, T. Hottkowitz, and H. Eibl Effects of miltefosine and other alkylphosphocholines on human intestinal parasite Entamoeba histolytica Antimicrob. Agents Chemother. 45 2001 1505 1510 (Pubitemid 32374125)
61. K. Seifert, A. Lemke, S.L. Croft, and O. Kayser Antileishmanial structure-activity relationships of synthetic phospholipids: in vitro and in vivo activities of selected derivatives Antimicrob. Agents Chemother. 51 2007 4525 4528 (Pubitemid 350209921)
62. K. Ukawa, E. Imamiya, H. Yamamoto, K. Mizuno, A. Tasaka, Z. Terashita, T. Okutani, H. Nomura, T. Kasukabe, M. Hozumi, I. Kudo, and K. Inoue Synthesis and antitumor activity of new alkylphospholipids containing modifications of the phosphocholine moiety Chem. Pharm. Bull. 37 1989 1249 1255 (Pubitemid 19151220)
63. J. Van Griensven, M. Balasegaram, F. Meheus, J. Alvar, L. De Lynen, and M. Boelaert Combination therapy for visceral leishmaniasis Lancet Infect. Dis. 10 2010 184 194
64. G.S. Visvesvara, and F.L. Schuster Opportunistic free living Amebae, Part I Clin. Microbiol. Newslett. 30 2008 151 158
65. J. Walochnik, M. Duchêne, K. Seifert, A. Obwaller, T. Hottkowitz, G. Wiedermann, H. Eibl, and H. Aspöck Cytotoxic activities of alkylphosphocholines against clinical isolates of Acanthamoeba spp. Antimicrob. Agents Chemother. 46 2002 695 701 (Pubitemid 34157653)
66. J. Walochnik, A. Obwaller, F. Gruber, M. Mildner, E. Tschachler, M. Suchomel, M. Duchêne, and H. Auer Anti-Acanthamoeba efficacy and toxicity of miltefosine in an organotypic skin equivalent J. Antimicrob. Chemother. 64 2009 539 545
67. Y. Weng, X. Guo, R.L. Gregory, and D. Xie Preparation and evaluation of an antibacterial dental cement containing quaternary ammonium salts J. Appl. Polym. Sci. 122 2011 2542 2551
68. F. Widmer, L.C. Wright, D. Obando, R. Handke, R. Ganendren, D.H. Ellis, and T.C. Sorrell Hexadecylphosphocholine (miltefosine) has a broad-spectrum fungicidal activity and is efficacious in a mouse model of cryptococcosis Antimicrob. Agents Chemother. 50 2006 414 421 (Pubitemid 43190947)
69. M. Yaseen, J.R. Lu, J.R.P. Webster, and J. Penfold Adsorption of single chain Zwitterionic phosphocholine surfactants: effects of length of alkyl chain and head group linker Biophys. Chem. 117 2005 263 273 (Pubitemid 41253601)
70. A.S. Zidan, Z. Rahman, and M.A. Khan Product and process understanding of a novel pediatric anti-HIV tenofovir niosomes with a high-pressure homogenizer Eur. J. Pharm. Sci. 44 2011 93 102